- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Merge eFilm achieves record revenues
Financial results for the third quarter, ended Sept. 30, at Merge eFilm showed a 44% increase in revenue over the year earlier period: $7.6 million compared with $5.3 million. Revenues were $20.2 million for the nine months ended Sept. 30, also an
Financial results for the third quarter, ended Sept. 30, at Merge eFilm showed a 44% increase in revenue over the year earlier period: $7.6 million compared with $5.3 million. Revenues were $20.2 million for the nine months ended Sept. 30, also an increase of 44% over the previous nine-month period. Net income for the quarter rose 55% to $1.6 million. Net income for the nine months increased 85% to $4.3 million. Results include approximately two and a half months of revenues from RIS Logic. The RIS Logic acquisition completed in late July strengthened Merge eFilm's product portfolio to include a full RIS/PACS solution. It also enhanced target market positioning and accelerated the effectiveness of operations, according to Richard A. Linden, Merge eFilm president and CEO.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
